Lluís Guirado

2.0k total citations
70 papers, 1.2k citations indexed

About

Lluís Guirado is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lluís Guirado has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Transplantation, 18 papers in Surgery and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lluís Guirado's work include Renal Transplantation Outcomes and Treatments (36 papers), Organ Donation and Transplantation (15 papers) and Renal and Vascular Pathologies (14 papers). Lluís Guirado is often cited by papers focused on Renal Transplantation Outcomes and Treatments (36 papers), Organ Donation and Transplantation (15 papers) and Renal and Vascular Pathologies (14 papers). Lluís Guirado collaborates with scholars based in Spain, Germany and France. Lluís Guirado's co-authors include Julio Pascual, Carme Facundo, Antonio Alcaraz, Jordi Bover, Olga Millán, Pablo Ureña‐Torres, Alberto Breda, Mireía Musquera, José‐Vicente Torregrosa and Ignasi Gich and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Lluís Guirado

68 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lluís Guirado Spain 21 427 318 251 249 218 70 1.2k
Catherine Horsfield United Kingdom 14 459 1.1× 417 1.3× 238 0.9× 163 0.7× 408 1.9× 40 1.3k
Marie‐Noelle Péraldi France 23 404 0.9× 327 1.0× 148 0.6× 309 1.2× 400 1.8× 51 1.6k
Jörg Beimler Germany 19 367 0.9× 234 0.7× 202 0.8× 92 0.4× 149 0.7× 45 975
Yoshihiko Watarai Japan 21 799 1.9× 570 1.8× 401 1.6× 297 1.2× 253 1.2× 141 1.6k
Jonathon Olsburgh United Kingdom 20 349 0.8× 532 1.7× 83 0.3× 379 1.5× 134 0.6× 79 1.3k
K. Tanabe Japan 20 669 1.6× 494 1.6× 192 0.8× 313 1.3× 232 1.1× 113 1.3k
E. Abderrahim Tunisia 15 192 0.4× 233 0.7× 143 0.6× 130 0.5× 132 0.6× 135 802
H W Sollinger United States 18 645 1.5× 646 2.0× 239 1.0× 244 1.0× 259 1.2× 70 1.5k
Nina Tolkoff‐Rubin United States 18 613 1.4× 432 1.4× 208 0.8× 85 0.3× 220 1.0× 29 1.2k
T. Ben Abdallah Tunisia 16 147 0.3× 240 0.8× 139 0.6× 125 0.5× 246 1.1× 198 1.0k

Countries citing papers authored by Lluís Guirado

Since Specialization
Citations

This map shows the geographic impact of Lluís Guirado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lluís Guirado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lluís Guirado more than expected).

Fields of papers citing papers by Lluís Guirado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lluís Guirado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lluís Guirado. The network helps show where Lluís Guirado may publish in the future.

Co-authorship network of co-authors of Lluís Guirado

This figure shows the co-authorship network connecting the top 25 collaborators of Lluís Guirado. A scholar is included among the top collaborators of Lluís Guirado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lluís Guirado. Lluís Guirado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pybus, Marc, Gemma Bullich, Mónica Furlano, et al.. (2021). Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. Nephrology Dialysis Transplantation. 37(4). 687–696. 47 indexed citations
2.
Territo, Angelo, Alberto Piana, Matteo Fontana, et al.. (2021). Step-by-step Development of a Cold Ischemia Device for Open and Robotic-assisted Renal Transplantation. European Urology. 80(6). 738–745. 19 indexed citations
3.
Colom, Helena, Olga Millán, Cristina Espinosa, et al.. (2021). Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients. PLoS ONE. 16(1). e0245880–e0245880. 11 indexed citations
4.
Guirado, Lluís, et al.. (2021). Assessment of Tacrolimus Neurotoxicity Measured by Retinal OCT. Transplantation Proceedings. 54(1). 80–86. 2 indexed citations
5.
Furlano, Mónica, Ferràn Torres, Marc Pybus, et al.. (2021). Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 15(5). 912–921. 6 indexed citations
6.
Aguado, Rocío, M.L. Agüera, Miguel Montejo, et al.. (2018). Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients. Human Immunology. 79(6). 499–505. 1 indexed citations
7.
Breda, Alberto, Angelo Territo, Lluís Gausa, et al.. (2017). Robotic kidney transplantation: one year after the beginning. World Journal of Urology. 35(10). 1507–1515. 28 indexed citations
8.
Gómez‐Roig, María Dolores, et al.. (2015). Relationship between smoking, HPV infection, and risk of Cervical cancer.. PubMed. 36(6). 677–80. 33 indexed citations
9.
Segundo, David San, Olga Millán, Pedro Muñoz, et al.. (2014). High Proportion of Pretransplantation Activated Regulatory T cells (CD4+CD25highCD62L+CD45RO+) Predicts Acute Rejection in Kidney Transplantation. Transplantation. 98(11). 1213–1218. 33 indexed citations
10.
Arias, M., Domingo Hernández, Lluís Guirado, et al.. (2013). Clinical profile and post-transplant anaemia in renal transplant recipients restarting dialysis after a failed graft: changing trends between 2001 and 2009. Clinical Kidney Journal. 6(2). 156–163.
11.
Guirado, Lluís. (2010). El donante incompatible en trasplante renal de donante vivo. Nefrología. 30(2). 94–99. 1 indexed citations
12.
Guirado, Lluís, Luís Almenar, J.F. Castroagudı́n, et al.. (2009). [Chronic nephropathy in non-kidney transplantation: [prevention, early diagnosis and management].. PubMed. 29(4 Suppl). 1–16. 1 indexed citations
13.
Takemoto, Steven K., Wolfgang Arns, Suphamai Bunnapradist, et al.. (2008). Expanding the Evidence Base in Transplantation: The Complementary Roles of Randomized Controlled Trials and Outcomes Research. Transplantation. 86(1). 18–25. 8 indexed citations
14.
Pallardó, Luis, Federico Oppenheimer, Lluís Guirado, et al.. (2007). Calcineurin Inhibitor Reduction Based on Maintenance Immunosuppression With Mycophenolate Mofetil in Renal Transplant Patients: POP Study. Transplantation Proceedings. 39(7). 2187–2189. 8 indexed citations
15.
García‐Maset, Rafael, et al.. (2005). Living Donor Renal Transplantation in Catalonia: Overall Results and Comparison of Survival With Cadaveric Donor Renal Transplantation. Transplantation Proceedings. 37(9). 3682–3683. 6 indexed citations
16.
Alcaraz, Antonio, Anna Bujons, Pablo de la Torre, et al.. (2005). Percutaneous Management of Transplant Ureteral Fistulae Is Feasible in Selected Cases. Transplantation Proceedings. 37(5). 2111–2114. 17 indexed citations
17.
Caballero, Francisco, et al.. (2005). Successful Liver and Kidney Transplantation From Cadaveric Donors With Left-Sided Bacterial Endocarditis. American Journal of Transplantation. 5(4). 781–787. 28 indexed citations
18.
Solà, Ricard, et al.. (2004). Tacrolimus/mycophenolate mofetil-based immunosuppression in aged kidney transplant. A prospective study. International Immunopharmacology. 5(1). 129–131. 2 indexed citations
19.
Solà, R., José María Díaz Fernández, Lluís Guirado, et al.. (2003). Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine. Transplantation Proceedings. 35(5). 1699–1700. 5 indexed citations
20.
Guirado, Lluís, José Muñóz, Núria Rabella, et al.. (2002). Use of cytomegalovirus antigenemia as a marker for preemptive treatment. Transplantation Proceedings. 34(1). 67–68. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Horsfield Breakdown of academic impact, for papers by Marie‐Noelle Péraldi Breakdown of academic impact, for papers by Jörg Beimler Breakdown of academic impact, for papers by Yoshihiko Watarai Breakdown of academic impact, for papers by Jonathon Olsburgh Breakdown of academic impact, for papers by K. Tanabe Breakdown of academic impact, for papers by E. Abderrahim Breakdown of academic impact, for papers by H W Sollinger Breakdown of academic impact, for papers by Nina Tolkoff‐Rubin Breakdown of academic impact, for papers by T. Ben Abdallah
Rankless by CCL
2026